MeSH tree: C04.588.614
New research from Peter Mac has uncovered why some parts of the brain may be more vulnerable to tumor growth than others, offering new clues into how brain cancers begin and how they could one day be stopped. Published in ...
May 21, 2026
0
4
Each year, approximately 2,000 people aged 18–39 are diagnosed with cancer in Sweden. Most survive their illness, but for many, life continues with long-term consequences. In a new doctoral dissertation, Charlotta Bergström ...
May 19, 2026
0
3
The U.S. Food and Drug Administration has approved a label expansion for Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with (gMG). The ...
May 18, 2026
0
6
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that people who gain the highest amount of weight across adulthood are at greatly increased risk of certain obesity-related ...
May 14, 2026
0
4
For females with myasthenia gravis, pregnancy is not associated with an increased risk of serious flare-ups of the disease, or new or worsening symptoms, according to a study published in Neurology. For a small percentage ...
May 13, 2026
0
2
Scientists are creating a glioblastoma 'tumor on a chip'—a tiny living system capable of mimicking the key features of the human brain and providing a deeper understanding of how the aggressive brain cancer works.
May 13, 2026
0
4
New multiplexed imaging technology using standard clinical MRI systems can simultaneously map more than 20 biomarkers in high resolution, providing a comprehensive view of the brain with a single scan.
May 6, 2026
0
22
Researchers at the University of Cincinnati Gardner Neuroscience Institute's Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy ...
May 4, 2026
0
14
In patients with myasthenia gravis, the surgical removal of the thymus gland, called thymectomy, added "quality adjusted life years" to patients and was also cost-effective in comparison to pharmacological treatment alone, ...
Apr 24, 2026
0
4
Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more likely to die of myocarditis, and myocarditis-specific fatality was more common in patients who experienced ...
Apr 21, 2026
0
4
